CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objectives: We hypothesized that CSF neurofilament light (NFL) levels would be elevated in dementias with subcortical involvement, including vascular dementia (VaD), but less elevated in dementias primarily affecting gray matter structures, such as Alzheimer disease (AD), and that elevated CSF NFL would correlate with disease severity and shorter survival time irrespective of clinical diagnosis.
Methods: We included 3,356 individuals with dementia who had CSF NFL analyzed in our laboratory between 2005 and 2012. Clinical diagnoses and Mini-Mental State Examination (MMSE) scores were obtained from the Swedish Dementia Registry, and in selected cases (n = 478), date of death from the Swedish Mortality Registry.
Results: CSF NFL differed among clinical diagnoses, with the highest levels seen in frontotemporal dementia, VaD, and mixed AD and VaD. Early-onset AD (younger than 65 years) had the lowest levels. High CSF NFL correlated with low MMSE score and short survival time irrespective of diagnosis, and was also particularly evident in AD.
Conclusions: CSF NFL differs among different neurodegenerative diseases and is especially high in dementias engaging subcortical brain regions, such as VaD and mixed AD and VaD, but also in frontotemporal dementia. The association of high CSF NFL levels with disease severity and short survival supports the notion that high CSF NFL levels indicate more aggressive disease processes.
GLOSSARY
- Aβ42=
- β-amyloid 1–42;
- AD=
- Alzheimer disease;
- CI=
- confidence interval;
- DLB=
- dementia with Lewy bodies;
- DSM-IV=
- Diagnostic and Statistical Manual of Mental Disorders, 4th edition;
- EAD=
- early-onset Alzheimer disease;
- FTD=
- frontotemporal dementia;
- HR=
- hazard ratio;
- ICD-10=
- International Classification of Diseases, tenth revision;
- IWG-2=
- International Working Group 2;
- LAD=
- late-onset Alzheimer disease;
- MIX=
- mixed Alzheimer disease and vascular dementia;
- MMSE=
- Mini-Mental State Examination;
- NFL=
- neurofilament light;
- PDD=
- Parkinson disease with dementia;
- p-tau=
- phosphorylated tau;
- SveDem=
- Swedish Dementia Registry;
- t-tau=
- total tau;
- VaD=
- vascular dementia
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Supplemental data at Neurology.org
- Received June 27, 2014.
- Accepted in final form August 22, 2014.
- © 2014 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Monitoring disease activity in multiple sclerosis using serum neurofilament light proteinLenka Novakova, Henrik Zetterberg, Peter Sundström et al.Neurology, October 27, 2017 -
Article
Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer DiseaseIgnacio Illán-Gala, Alberto Lleo, Anna Karydas et al.Neurology, November 16, 2020 -
Article
Plasma and CSF neurofilament lightRelation to longitudinal neuroimaging and cognitive measuresMichelle M. Mielke, Jeremy A. Syrjanen, Kaj Blennow et al.Neurology, June 10, 2019 -
Article
Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sportsPashtun Shahim, Henrik Zetterberg, Yelverton Tegner et al.Neurology, April 12, 2017